+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pentobarbital"

Sedative-Hypnotic Drugs Market Report 2025 - Product Thumbnail Image

Sedative-Hypnotic Drugs Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Plumb's Veterinary Drug Handbook. Edition No. 10 - Product Thumbnail Image

Plumb's Veterinary Drug Handbook. Edition No. 10

  • Book
  • July 2023
  • 1568 Pages
  • 4 Results (Page 1 of 1)
Loading Indicator

Pentobarbital is a barbiturate drug used to treat a variety of conditions related to the central nervous system. It is used to treat seizures, insomnia, and anxiety, as well as to induce anesthesia and sedation. Pentobarbital is also used in veterinary medicine to euthanize animals. It is a Schedule II controlled substance in the United States, meaning it has a high potential for abuse and addiction. Pentobarbital is available in both generic and brand-name forms. It is typically administered orally, intravenously, or intramuscularly. Common side effects include drowsiness, dizziness, and confusion. Long-term use of pentobarbital can lead to physical and psychological dependence. Some companies that produce pentobarbital include Mylan Pharmaceuticals, Teva Pharmaceuticals, and Sandoz. Show Less Read more